Florida State University

Summary

Florida State University is a medical facility located in Tallahassee, Florida. This center is recognized for care of Obesity, Anxiety Disorders, Depression, Anxiety, High Blood Pressure and other specialties. Florida State University is involved with conducting 75 clinical trials across 134 conditions. There are 6 research doctors associated with this hospital, such as Jie Chen, Justin Riddle, PhD, Alexandria Meyer, PhD, and Walter Boot, PhD.

Top PIs

Clinical Trials running at Florida State University

Post-Traumatic Stress Disorder

Obesity

Depression

Dysarthria

Anxiety Disorders

Parkinson's Disease

Public Speaking

Asthma

Prostate Cancer

Traumatic Brain Injury

Breathwork

for Post-Traumatic Stress Disorder

The goal of this single-site, single-arm pilot study is to examine the impact of breathwork training for posttraumatic stress symptoms in an adult veteran population. Participants will complete a single, in-person breathwork session (2 hours) led by a certified breathwork facilitator and engage in an integration session (30 minute) with a licensed psychologist. Participants will be invited to engage in two, optional, virtual follow up breathwork sessions (40 minute practice each) during weeks 2 and 3 following the in-person breathwork session.

Recruiting

1 award

N/A

2 criteria

OTX-601

for PTSD

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Recruiting

1 award

Phase 2

1 criteria

STAIR-NT

for PTSD and Substance Abuse

During this 36-month R34 trial, eight study phases are proposed to adapt an evidence-based post traumatic stress disorder (PTSD) intervention (STAIR-NT) and layer it into a methadone maintenance treatment (MMT) program (START Treatment and Recovery centers) in New York City for use among individuals engaged in stimulant-opioid polysubstance use. The study aims to adapt STAIR-NT to a massed treatment schedule. Once an adapted protocol is complete, it will be tested for feasibility, acceptability, and short-term polysubstance and PTSD symptomology outcomes in a pilot randomized control trial (RCT) of 80 participants. Participants who screen eligible and consent will be randomized 1:1 to the adapted STAIR-NT intervention or treatment as usual (TAU) using randomization blocks of two and two and four via a computer-generated randomization sequence. Participants assigned to the intervention will receive the adapted massed delivery of STAIR-NT by trained counselors.

Recruiting

1 award

N/A